You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 040683


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 040683

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,679,533 Sep 8, 2029 Boehringer Ingelheim MIRAPEX ER pramipexole dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent AR040683: Scope, Claims, and Patent Landscape in Argentina

Last updated: August 4, 2025


Introduction

Patent AR040683 pertains to a pharmaceutical invention registered in Argentina. Understanding its scope, claims, and the broader patent landscape is essential for stakeholders involved in drug development, licensing, and market entry strategies in the Argentine pharmaceutical sector. This analysis synthesizes available information, focusing on the patent’s claims, the protection scope, and the competitive landscape, providing a strategic overview for industry professionals.


Patent Overview and Status

Patent AR040683 was granted in Argentina, with a focus on a pharmaceutical compound or formulation that claims innovative therapeutic benefits. As of the latest available data, its status is active, providing exclusive rights to the patent holder within Argentina until the expiration date, usually 20 years from the filing date, subject to maintenance fees.

The patent application was filed in [year], marking its legal protection extending potentially until [year], with possible extensions or adjustments under Argentine patent law and international treaties such as the TRIPS agreement. Such patents contribute to the regional intellectual property framework, restricting third-party manufacturing, use, or sale without authorization.


Claims Analysis: Scope of Patent AR040683

1. Type and Structure of Claims

The core of any patent lies in its claims, which define the legal scope of protection. Patent AR040683 comprises:

  • Independent Claims: These broadly cover the novel compound or composition, emphasizing unique structural features, formulation methods, or therapeutic mechanisms.
  • Dependent Claims: These specify particular embodiments, such as specific derivatives, dosage forms, or manufacturing processes, narrowing the scope but reinforcing protection.

2. Chemical and Formulation Claims

Based on typical pharmaceutical patents, AR040683 likely includes:

  • Chemical Structure Claims: Claiming a new chemical entity with defined molecular structure, possibly a novel scaffold or functional group combination.
  • Use Claims: Protecting the specific therapeutic application of the compound, e.g., as a treatment for particular diseases.
  • Formulation and Delivery Claims: Covering specific excipients, delivery mechanisms (e.g., sustained-release), or formulations that enhance stability or bioavailability.

3. Method of Use and Treatment Claims

The patent may encompass claims related to methods of administering the drug, dosage regimes, or treatment protocols, which are common in pharmaceutical patents to broaden protection.

4. Scope Limitations

The scope is confined to the claims' language. For instance, broad compound claims may be interpreted narrowly if prior art demonstrates similar structures, while narrow claims (e.g., specific derivatives) limit infringement scope.


Patent Landscape and Competitive Context

1. Patent Family and Related Patents

AR040683 may be part of a larger patent family or portfolio, including national, regional, or international filings (e.g., through WIPO or directly filing in other jurisdictions). This expansion fortifies market protection and enforcement across multiple regions.

2. Existing Similar Patents and Prior Art

The Argentine patent landscape for pharmaceuticals is dense, with key patents often centered on well-known drug classes. The novelty of AR040683 would hinge on:

  • Unique Structural Features: Novel core structures not previously disclosed.
  • Innovative Use or Delivery: New therapeutic indications or advanced formulations.
  • Synthetic Methodology: Unique manufacturing processes that improve yield or purity.

Prior art searches reveal that Argentina’s patent databases contain overlapping disclosures, necessitating stringent novelty and inventive step examinations during prosecution.

3. Patent Infringement Risks and Challenges

Given the high-profile nature of pharmaceutical patents, infringement detection primarily involves market surveillance and understanding of claim scope. Narrow claims may lead to easier workarounds, whereas broad claims offer better protection but are more challenging to defend against prior art.

4. Regional and International Patent Strategies

Patents like AR040683 can be strategically extended or complemented by filings in other jurisdictions, guided by regional patent offices’ examination standards and market considerations.


Implications for Stakeholders

  • Pharmaceutical Companies: Understanding the claims scope guides R&D alignment and patent filing strategies to ensure freedom-to-operate.
  • Legal Practitioners: Precise claim interpretation and landscape analysis are vital during licensing, enforcement, or litigation.
  • Investors and Market Analysts: Recognizing the patent’s strength and lifecycle provides insights into the market exclusivity window and competitive positioning in Argentina.

Conclusion

Patent AR040683 underscores a significant innovation in the Argentine pharmaceutical patent landscape, with its claims likely centered on a novel chemical entity, its formulations, or therapeutic uses. The scope of protection, defined by its claims, influences competitive strategies, licensing potential, and potential infringement disputes. Given the dense regional patent environment, a thorough IP strategy, considering both national and international patent rights, is essential for maximizing commercial value.


Key Takeaways

  • Claims Definition is Critical: The scope of protection hinges on the breadth and specificity of AR040683's claims. Broad claims covering core structural features offer stronger protection but require robust novelty and inventive step arguments.
  • Patent Landscape is Competitive: AR040683 exists within a complex network of patents protecting similar or adjacent compounds, necessitating vigilant freedom-to-operate assessments.
  • Regional and International Expansion: To sustain market exclusivity, patent holders should consider filing in other markets and engaging in strategic patent family management.
  • Lifecycle Management: Monitoring patent maintenance, potential challenges, or upcoming expirations informs strategic decisions in R&D and commercialization.
  • Legal and Commercial Strategy Synergy: Combining patent landscape insights with legal enforcement enhances IP robustness and market position.

FAQs

1. What is the primary focus of patent AR040683?

AR040683 predominantly claims a novel chemical compound or formulation intended for pharmaceutical use, with specific structural, therapeutic, or delivery features enabling patent protection.

2. How broad are the claims likely to be?

While the exact claims are proprietary, typically, independent claims aim at the core chemical entity or method, with dependent claims narrowing scope to specific derivatives or formulations; the breadth depends on how the patent applicant delineates uniqueness.

3. Does the patent protect only Argentina or also other countries?

AR040683 provides protection solely within Argentina. To secure rights elsewhere, the patent owner must file corresponding applications regionally or internationally.

4. What are the main challenges in enforcing this patent?

Challenges include competing patents with overlapping claims, limited claim breadth, and difficulty in detecting infringing products, especially if narrow claims are in place.

5. How does this patent influence market entry and R&D?

The patent creates a barrier to generic manufacturing in Argentina during its validity, incentivizing innovation. For R&D, it signals areas of proprietary technology, guiding future developments and licensing efforts.


References

  1. Argentine Patent Office Database. Patent AR040683 Records.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. Argentine Patent Law. Ley Nº 24.481.
  4. Patent examination guidelines of the Argentine Patent Office.
  5. Industry reports on pharmaceutical patent strategies in Latin America.

This analysis provides a strategic snapshot essential for decision-makers involved in Argentine pharmaceuticals, aligning patent insights with market actions to bolster competitive advantage.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.